NCT02176005View on ClinicalTrials.gov

Safety and Efficacy Study of DAV132 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy
Interventions
DEVICE

DAV132

DAV132 is associated to moxifloxacin or it is evaluated alone

DRUG

Moxifloxacin

Moxifloxacin is used alone or associated to DAV132

OTHER

Negative Control

Moxifloxacin is used alone

Trial Locations (1)

75O18

CLINICAL INVESTIGATION CENTER (CIC), Groupe Hospitalier Bichat-Claude Bernard, Paris

Sponsors

Lead Sponsor

Da Volterra
All Listed Sponsors
lead

Da Volterra

INDUSTRY

NCT02176005 - Safety and Efficacy Study of DAV132 in Healthy Volunteers | Biotech Hunter | Biotech Hunter